Literature DB >> 11207600

Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape.

T C Dixon1, A A Fadl, T M Koehler, J A Swanson, P C Hanna.   

Abstract

This study describes early intracellular events occurring during the establishment phase of Bacillus anthracis infections. Anthrax infections are initiated by dormant endospores gaining access to the mammalian host and becoming engulfed by regional macrophages (Mphi). During systemic anthrax, late stage events include vegetative growth in the blood to very high titres and the synthesis of the anthrax exotoxin complex, which causes disease symptoms and death. Experiments focus on the early events occurring during the first few hours of the B. anthracis infectious cycle, from endospore germination up to and including release of the vegetative cell from phagocytes. We found that newly vegetative bacilli escape from the phagocytic vesicles of cultured Mphi and replicate within the cytoplasm of these cells. Release from the Mphi occurs 4-6 h after endospore phagocytosis, timing that correlates with anthrax infection of test animals. Genetic analysis from this study indicates that the toxin plasmid pXO1 is required for release from the Mphi, whereas the capsule plasmid pXO2 is not. The transactivator atxA, located on pXO1, is also found to be essential for release, but the toxin genes themselves are not required. This suggests that Mphi release of anthrax bacilli is atxA regulated. The putative 'escape' genes may be located on the chromosome and/or on pXO1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11207600     DOI: 10.1046/j.1462-5822.2000.00067.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  105 in total

1.  Tracking bacterial infection of macrophages using a novel red-emission pH sensor.

Authors:  Yuguang Jin; Yanqing Tian; Weiwen Zhang; Sei-Hum Jang; Alex K-Y Jen; Deirdre R Meldrum
Journal:  Anal Bioanal Chem       Date:  2010-08-19       Impact factor: 4.142

2.  Morphogenesis of the Bacillus anthracis spore.

Authors:  Rebecca Giorno; Joel Bozue; Christopher Cote; Theresa Wenzel; Krishna-Sulayman Moody; Michael Mallozzi; Matthew Ryan; Rong Wang; Ryszard Zielke; Janine R Maddock; Arthur Friedlander; Susan Welkos; Adam Driks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.

Authors:  Nam-Kyu Lim; Jung-Hwan Kim; Mee Sook Oh; Sangyoon Lee; Se-Yeon Kim; Keun-Soo Kim; Hyun-Jung Kang; Hyo Jeong Hong; Kyung-Soo Inn
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides.

Authors:  Shalaka Samant; Fong-Fu Hsu; Alexander A Neyfakh; Hyunwoo Lee
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

5.  Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant.

Authors:  Brandon Feinen; Nikolai Petrovsky; Anita Verma; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

6.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress.

Authors:  Robert J Cybulski; Patrick Sanz; Farhang Alem; Scott Stibitz; Robert L Bull; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Transcriptional profiling of Bacillus anthracis during infection of host macrophages.

Authors:  Nicholas H Bergman; Erica C Anderson; Ellen E Swenson; Brian K Janes; Nathan Fisher; Matthew M Niemeyer; Amy D Miyoshi; Philip C Hanna
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  Effect of Bacillus anthracis virulence factors on human dendritic cell activation.

Authors:  Andrew C Hahn; C Rick Lyons; Mary F Lipscomb
Journal:  Hum Immunol       Date:  2008-07-26       Impact factor: 2.850

10.  BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.

Authors:  Justin Kern; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.